Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hetherington

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Prostate Cancer and Prostatic Diseases|November 15, 2006
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth, C Tyrrell, K Delaere, et al.
Journal of the Royal Society, Interface|June 17, 2011
A composite computational model of liver glucose homeostasis. I. Building the composite modelJ Hetherington, T Sumner, R M Seymour, et al.
Cancer Research|December 6, 2006
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signalingSusumu Kobayashi, Takeshi Shimamura, Stefano Monti, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Nature|April 14, 1988
The nature and origin of interstellar diamondD F Blake, F Freund, K F Krishnan, et al.
Nature Genetics|March 1, 1997
Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion geneD A Yergeau, C J Hetherington, Q Wang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 1, 1980
Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defectsM F Armaly, D E Krueger, L Maunder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853F C da Silva, S D Fossa, N K Aaronson, et al.
Nature Plants|September 4, 2023
Evolution of phenotypic disparity in the plant kingdomJames W Clark, Alexander J Hetherington, Jennifer L Morris, et al.
Urology|August 8, 2001
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progressionM Wirth, C Tyrrell, M Wallace, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Prostate Cancer and Prostatic Diseases|November 15, 2006
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth, C Tyrrell, K Delaere, et al.
Journal of the Royal Society, Interface|June 17, 2011
A composite computational model of liver glucose homeostasis. I. Building the composite modelJ Hetherington, T Sumner, R M Seymour, et al.
Cancer Research|December 6, 2006
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signalingSusumu Kobayashi, Takeshi Shimamura, Stefano Monti, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Nature|April 14, 1988
The nature and origin of interstellar diamondD F Blake, F Freund, K F Krishnan, et al.
Nature Genetics|March 1, 1997
Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion geneD A Yergeau, C J Hetherington, Q Wang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 1, 1980
Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defectsM F Armaly, D E Krueger, L Maunder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853F C da Silva, S D Fossa, N K Aaronson, et al.
Nature Plants|September 4, 2023
Evolution of phenotypic disparity in the plant kingdomJames W Clark, Alexander J Hetherington, Jennifer L Morris, et al.
Urology|August 8, 2001
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progressionM Wirth, C Tyrrell, M Wallace, et al.
Pageof 18